Wen-Yu Pan

1.5k total citations
27 papers, 1.3k citations indexed

About

Wen-Yu Pan is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Wen-Yu Pan has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Wen-Yu Pan's work include Cancer therapeutics and mechanisms (7 papers), Immunotherapy and Immune Responses (5 papers) and Nanoplatforms for cancer theranostics (4 papers). Wen-Yu Pan is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Immunotherapy and Immune Responses (5 papers) and Nanoplatforms for cancer theranostics (4 papers). Wen-Yu Pan collaborates with scholars based in Taiwan, United States and Czechia. Wen-Yu Pan's co-authors include Hsing‐Wen Sung, Jang‐Yang Chang, Chieh‐Cheng Huang, Ching‐Chuan Kuo, Wei-Chih Lin, Meng‐Ju Li, Chiranjeevi Korupalli, Li‐Tzong Chen, Yen Chang and Jing‐Ping Liou and has published in prestigious journals such as ACS Nano, The Journal of Immunology and Biomaterials.

In The Last Decade

Wen-Yu Pan

27 papers receiving 1.3k citations

Peers

Houría Boulaiz Spain

René C.‐Gaudreault Canada

Emilia Licărete Romania

Manuela Banciu Romania

Edgar Pérez‐Herrero Spain

Rajiv P. Gude India

Shan‐Yu Fung Canada

Hanqing Qian China

Chaofeng Mu China

George Mattheolabakis United States

Houría Boulaiz Spain View profile →

Citations per field, relative to Wen-Yu Pan

Wen-Yu Pan · 1×

×1.8 928

MB

×1.0 406

BE

×0.7 194

OC

×0.6 149

IMMUN

×1.7 332

ONCOL

Citations per year, relative to Wen-Yu Pan

Wen-Yu Pan · 1×

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Countries citing papers authored by Wen-Yu Pan

Since Specialization

Citations

This map shows the geographic impact of Wen-Yu Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen-Yu Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen-Yu Pan more than expected).

Fields of papers citing papers by Wen-Yu Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen-Yu Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen-Yu Pan. The network helps show where Wen-Yu Pan may publish in the future.

Co-authorship network of co-authors of Wen-Yu Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Wen-Yu Pan. A scholar is included among the top collaborators of Wen-Yu Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen-Yu Pan. Wen-Yu Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Polyethyleneimine/fucoidan polyplexes as vaccine carriers for enhanced antigen loading and dendritic cell activation	International Journal of Biological Macromolecules	Jen-Ron Chiang, Tzu‐Shun Lin et al.	1
2	Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma	Journal of Controlled Release	Wen-Yu Pan, Pei-Ru Jheng et al.	6
3	Pollen-Mimetic Metal–Organic Frameworks with Tunable Spike-Like Nanostructures That Promote Cell Interactions to Improve Antigen-Specific Humoral Immunity	ACS Nano	Wen-Yu Pan, Chih‐Yang Huang et al.	33
4	In situ self-spray coating system that can uniformly disperse a poorly water-soluble H2S donor on the colorectal surface to treat inflammatory bowel diseases	Biomaterials	Wei-Chih Lin, Wen-Yu Pan et al.	35
5	Localized sequence-specific release of a chemopreventive agent and an anticancer drug in a time-controllable manner to enhance therapeutic efficacy	Biomaterials	Wen-Yu Pan, Kun‐Ju Lin et al.	20
6	Acidity-triggered charge-convertible nanoparticles that can cause bacterium-specific aggregation in situ to enhance photothermal ablation of focal infection	Biomaterials	Chiranjeevi Korupalli, Chieh‐Cheng Huang et al.	152
7	Multimodality noninvasive imaging for assessing therapeutic effects of exogenously transplanted cell aggregates capable of angiogenesis on acute myocardial infarction	Biomaterials	Chieh‐Cheng Huang, Hao-Ji Wei et al.	21
8	Synergistic antibacterial effects of localized heat and oxidative stress caused by hydroxyl radicals mediated by graphene/iron oxide-based nanocomposites	Nanomedicine Nanotechnology Biology and Medicine	Wen-Yu Pan, Chieh‐Cheng Huang et al.	120
9	Enhancement of cell adhesion, retention, and survival of HUVEC/cbMSC aggregates that are transplanted in ischemic tissues by concurrent delivery of an antioxidant for therapeutic angiogenesis	Biomaterials	Chieh‐Cheng Huang, Wen-Yu Pan et al.	31
10	MPT0B098, a Novel Microtubule Inhibitor That Destabilizes the Hypoxia-Inducible Factor-1α mRNA through Decreasing Nuclear–Cytoplasmic Translocation of RNA-Binding Protein HuR	Molecular Cancer Therapeutics	Jing‐Ping Liou, Ching‐Chuan Kuo et al.	32
11	Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: The role of IL-6 signaling and Nrf2/AKR1C axis identification	Biochemical Pharmacology	Chih‐Cheng Chen, Ko‐Jiunn Liu et al.	49
12	Cancer Immunotherapy Using a Membrane-bound Interleukin-12 With B7-1 Transmembrane and Cytoplasmic Domains	Molecular Therapy	Wen-Yu Pan, Chun‐Chi Chen et al.	31
13	Enhancement of non-homologous end joining DNA repair capacity confers cancer cells resistance to the novel selenophene compound, D-501036	Cancer Letters	Yung‐Ning Yang, Kai-Ming Chou et al.	8
14	Chamaecypanone C, a novel skeleton microtubule inhibitor, with anticancer activity by trigger caspase 8-Fas/FasL dependent apoptotic pathway in human cancer cells	Biochemical Pharmacology	Cheng‐Chih Hsieh, Yueh‐Hsiung Kuo et al.	23
15	Synthesis and antitumor activity of 5-(9-acridinylamino)anisidine derivatives	Bioorganic & Medicinal Chemistry	Jang‐Yang Chang, Yi‐Wen Lin et al.	30
16	Four New 6-Nor-5(6→7)abeo-abietane Type Diterpenes and Antitumoral Cytotoxic Diterpene Constituents from the Bark ofTaiwania cryptomerioides	Planta Medica	Chi-I Chang, Jang‐Yang Chang et al.	73
17	A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells	Biochemical Pharmacology	Shin‐Hun Juang, Wen-Yu Pan et al.	14
18	Antitumor and Antimetastatic Activity of IL-23	The Journal of Immunology	Shan‐Chih Lee, Wen-Yu Pan et al.	140
19	New analogues of AHMA as potential antitumor agents: synthesis and biological activity	Bioorganic & Medicinal Chemistry	Jang‐Yang Chang, Wen-Yu Pan et al.	23
20	Antitumor AHMA Linked to DNA Minor Groove Binding Agents: Synthesis and Biological Evaluation	Journal of Medicinal Chemistry	Jang‐Yang Chang, Wen-Yu Pan et al.	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact